Showing results (1711-1720 of 1,752) with videos related to

Sort By:
Pageof 176
European Journal of Cancer (Oxford, England : 1990)|May 17, 2019
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)Celeste Lebbe, Claus Garbe, Alexander J Stratigos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 17, 2022
One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohortPaul Loubet, Linda Wittkop, Laetitia Ninove, et al.
Cells|March 25, 2022
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and CancerMarine Baron, Cathia Soulié, Armelle Lavolé, et al.
Cancers|October 13, 2021
Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort StudyMarc-Antoine Benderra, Ainhoa Aparicio, Judith Leblanc, et al.
International Journal of Molecular Sciences|June 10, 2022
Expanding the Molecular Spectrum of ANKRD11 Gene Defects in 33 Patients with a Clinical Presentation of KBG SyndromeIlaria Bestetti, Milena Crippa, Alessandra Sironi, et al.
Food and Environmental Virology|March 6, 2026
Assessing Urban Ditches for Tracking SARS-CoV-2 in Low Sanitation Areas in Southeastern BrazilRegina Keller, Gizely Azevedo Costa, Paola de Avelar Carpinetti, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 3, 2025
PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop reportSylvia Szentpetery, Dara Riva, Yair J Blumenfeld, et al.
BMC Infectious Diseases|September 28, 2024
Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participantsMathieu Chalouni, Paul Loubet, Edouard Lhomme, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2018
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup studyMaria Pia Pistillo, Vincenzo Fontana, Anna Morabito, et al.
Vaccine|August 23, 2025
Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART studyLiem Binh Luong Nguyen, Lyvia Magloire, Alexis François, et al.
Pageof 176